A peptide isolated from a patient on continuous ambulatory peritoneal dialysis has homology to ubiquitin and inhibits the chemotactic response of polymorphonuclear leukocytes

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 210-213

  Cohen, Gerald ^a   Rudnicki, Michael ^b   Hörl, Walter H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Chemotaxis; Continuous ambulatory peritoneal dialysis; Infection; Polymorphonuclear leukocytes; Ubiquitin; Uremic toxins

Indexed keywords

UBIQUITIN; UREMIC TOXIN;

CASE REPORT; CHEMOTAXIS; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOELECTRIC POINT; NEUTROPHIL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; UREMIA;

CHEMOTAXIS, LEUKOCYTE; HUMANS; NEUTROPHILS; PEPTIDES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITINS; UREMIA;

BACTERIA (MICROORGANISMS);

EID: 0030689671     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Holmes CJ: Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int 1994;46(suppl 48):S58-S70.
2. Ho-Dac-Pannekeet MM, Krediet RT: Inflammatory changes in vivo during CAPD: What can the effluent tell us? Kidney Int 1996;50(suppl 56):S12-S16.
3. Downey GP: Mechanisms of leukocyte motility and chemotaxis. Curr Opin Immunol 1994;6:113-124.
4. Metcoff J, Lindeman R, Baxter D, Pederson J: Cell metabolism in uremia. Am J Clin Nutr 1978;31:1627-1634.
5. Siriwatratananonta P, Sinsakul V, Stern K, Slavin RG: Defective chemotaxis in uremia. J Lab Clin Med 1978;92:402-407.
6. Mansell MA, Grimes AJ, Jones NF: Leucocyte ATP and renal failure. Clin Science 1981;61:43-46.
7. Ritchey EE, Wallin JD, Shah SV: Chemoluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 1981;19:349-358.
8. Cannistra SA, Griffin JD: Regulation of the production and function of granulocytes and monocytes. Semin Hematol 1988;25:173-188.
9. Vanholder R, Lameire N, Waterloos MA, Ringoir S: Depression of PMNL-response to phagocytic challenge in the presence of CAPD-effluent (abstract). Am J Soc Nephrol 1993;4:419A.
10. Cohen G, Haag-Weber M, Mai B, Deicher R, Hörl WH: Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995;6:1592- 1599.
11. Cohen G, Rudnicki M, Hörl WH: Isolation of modified ubiquitin as neutrophil chemotaxis inhibitor from uremic patients. J Am Soc Nephrol, in press.
12. Nauseef WM, Metcalf JA, Root RK: Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood 1983;61:483-492.
13. Metcalf JA, Gallin JI, Nauseef WM, Root RK: Laboratory Manual of Neutrophil Function. New York, Raven, 1986; pp 2-5.
14. Nelson RD, Quie PG, Simmons RL: Chemotaxis under agarese: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975;115:1650-1655.
15. Haas AL, Murphy KE, Bright PM: The inactivation of ubiquitin accounts for the inability to demonstrate ATP, ubiquitin-dependent proteolysis in liver extracts. J Biol Chem 1985;260:4694-4703.
16. Schlesinger DH, Goldstein G: Molecular conservation of 74 amino acid sequence of ubiquitin between cattle and man. Nature 1975;255:423-424.
17. Goldstein G, Scheid M, Hammerling U, Boyse EA, Schlesinger DH, Niall HD: Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci USA 1975;72:11-15.
18. Hershko A: Ubiquitin-mediated protein degradation. J Biol Chem 1988;263:15237-15240.
19. Hochstrasser M: Protein degradation or regulation: Ub the Judge. Cell 1996;84:813-815.
20. Pancré V, Pierce RJ, Foutnier F, Methali M, Delanoye A, Capron A, Auriault C: Effect of ubiquitin on platelet functions: Possible identity with platelet activity suppressive lymphokine (PASL). Eur J Immunol 1991;21:2735-2741.
21. Okada M, Miyazaki S, Hirasawa Y: Increase in plasma concentration of ubiquitin in dialysis patients: Possible involvement in beta2-microglobulin. Clin Chim Acta 1993;220:135-144.
22. Roxborough HE, Millar CA, Mac Eneny J, Young IS: Carbamylation inhibits the ferroxidase activity of caeruloplasmin. Biochem Biophys Res Commun 1995;214:1073-1078.
23. Stark GR, Stein WH, Moore S: Reactions of the cyanate present in aqueous urea with aminoacids and proteins. J Biol Chem 1960;235:3177-3181.
24. Schleicher E, Wieland OH: Protein glycation: Measurement and clinical relevance. J Clin Chem Clin Biochem 1989;27:577-587.
25. Lamb E, Cartel WR, Dawnay A: Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci 1993;84: 619-626.